Neurocrine Biosciences, Inc. (NBIX)
157.82
+1.06
(+0.68%)
USD |
NASDAQ |
Sep 02, 16:00
157.82
0.00 (0.00%)
After-Hours: 20:00
Neurocrine Biosciences Cash and Short Term Investments (Quarterly) : 389.80M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 389.80M |
| March 31, 2026 | 1.316B |
| December 31, 2025 | 1.480B |
| September 30, 2025 | 1.115B |
| June 30, 2025 | 975.60M |
| March 31, 2025 | 943.50M |
| December 31, 2024 | 1.076B |
| September 30, 2024 | 1.228B |
| June 30, 2024 | 1.039B |
| March 31, 2024 | 1.211B |
| December 31, 2023 | 1.032B |
| September 30, 2023 | 1.095B |
| June 30, 2023 | 976.70M |
| March 31, 2023 | 894.60M |
| December 31, 2022 | 989.30M |
| September 30, 2022 | 799.40M |
| June 30, 2022 | 648.30M |
| March 31, 2022 | 664.90M |
| December 31, 2021 | 711.30M |
| September 30, 2021 | 765.90M |
| June 30, 2021 | 884.90M |
| March 31, 2021 | 873.70M |
| December 31, 2020 | 801.00M |
| September 30, 2020 | 944.70M |
| June 30, 2020 | 948.30M |
| Date | Value |
|---|---|
| March 31, 2020 | 771.70M |
| December 31, 2019 | 670.52M |
| September 30, 2019 | 670.62M |
| June 30, 2019 | 619.98M |
| March 31, 2019 | 524.07M |
| December 31, 2018 | 650.91M |
| September 30, 2018 | 635.34M |
| June 30, 2018 | 508.74M |
| March 31, 2018 | 460.48M |
| December 31, 2017 | 515.93M |
| September 30, 2017 | 511.02M |
| June 30, 2017 | 525.02M |
| March 31, 2017 | 235.58M |
| December 31, 2016 | 307.35M |
| September 30, 2016 | 353.04M |
| June 30, 2016 | 387.40M |
| March 31, 2016 | 381.52M |
| December 31, 2015 | 379.19M |
| September 30, 2015 | 376.84M |
| June 30, 2015 | 384.72M |
| March 31, 2015 | 370.01M |
| December 31, 2014 | 193.81M |
| September 30, 2014 | 179.67M |
| June 30, 2014 | 194.66M |
| March 31, 2014 | 219.86M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Amarin Corp. Plc | 314.85M |
| Liquidia Corp. | 284.18M |
| Incyte Corp. | 4.536B |
| Halozyme Therapeutics, Inc. | 231.00M |
| Iovance Biotherapeutics, Inc. | 297.67M |